| In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties C le Viseur, M Hotfilder, S Bomken, K Wilson, S Röttgers, A Schrauder, ... Cancer cell 14 (1), 47-58, 2008 | 345 | 2008 |
| Understanding the cancer stem cell S Bomken, K Fišer, O Heidenreich, J Vormoor British journal of cancer 103 (4), 439-445, 2010 | 282 | 2010 |
| Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults P Milne, V Bigley, CM Bacon, A Néel, N McGovern, S Bomken, M Haniffa, ... Blood, The Journal of the American Society of Hematology 130 (2), 167-175, 2017 | 178 | 2017 |
| Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma RA Noble, N Bell, H Blair, A Sikka, H Thomas, N Phillips, S Nakjang, ... Haematologica 102 (7), 1247, 2017 | 129 | 2017 |
| Identification of new Wilms tumour predisposition genes: an exome sequencing study S Mahamdallie, S Yost, E Poyastro-Pearson, E Holt, A Zachariou, S Seal, ... The Lancet Child & Adolescent Health 3 (5), 322-331, 2019 | 107 | 2019 |
| Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populations K Rehe, K Wilson, S Bomken, D Williamson, J Irving, ML den Boer, ... EMBO molecular medicine 5 (1), 38-51, 2013 | 107 | 2013 |
| The oncogenic transcription factor RUNX1/ETO corrupts cell cycle regulation to drive leukemic transformation N Martinez-Soria, L McKenzie, J Draper, A Ptasinska, H Issa, S Potluri, ... Cancer Cell 34 (4), 626-642. e8, 2018 | 99 | 2018 |
| The ability to cross the blood–cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts MTS Williams, YM Yousafzai, A Elder, K Rehe, S Bomken, ... Blood, The Journal of the American Society of Hematology 127 (16), 1998-2006, 2016 | 76 | 2016 |
| Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents A Attarbaschi, E Carraro, O Abla, S Barzilai-Birenboim, S Bomken, ... haematologica 101 (12), 1581, 2016 | 69 | 2016 |
| Differential expression of miR-17∼ 92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia M Scherr, A Elder, K Battmer, D Barzan, S Bomken, M Ricke-Hoch, ... Leukemia 28 (3), 554-565, 2014 | 68 | 2014 |
| The KMT2A recombinome of acute leukemias in 2023 C Meyer, P Larghero, B Almeida Lopes, T Burmeister, D Gröger, R Sutton, ... Leukemia 37 (5), 988-1005, 2023 | 65 | 2023 |
| Current understanding and future research priorities in malignancy associated with inborn errors of immunity and DNA repair disorders: the perspective of an interdisciplinary … S Bomken, J van der Werff Ten Bosch, A Attarbaschi, CM Bacon, ... Frontiers in Immunology 9, 2912, 2018 | 60 | 2018 |
| Non-anaplastic peripheral T cell lymphoma in children and adolescents—an international review of 143 cases K Mellgren, A Attarbaschi, O Abla, S Alexander, S Bomken, E Bubanska, ... Annals of hematology 95, 1295-1305, 2016 | 56 | 2016 |
| Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia E Khabirova, L Jardine, THH Coorens, S Webb, TD Treger, J Engelbert, ... Nature medicine 28 (4), 743-751, 2022 | 50 | 2022 |
| Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression S Bomken, L Buechler, K Rehe, F Ponthan, A Elder, H Blair, CM Bacon, ... Leukemia 27 (3), 718-721, 2013 | 50 | 2013 |
| ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children ADJ Pearson, N Scobie, K Norga, F Ligas, D Chiodin, A Burke, ... European Journal of Cancer 110, 74-85, 2019 | 46 | 2019 |
| Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia A Elder, S Bomken, I Wilson, HJ Blair, S Cockell, F Ponthan, K Dormon, ... Leukemia 31 (12), 2577-2586, 2017 | 42 | 2017 |
| Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia R Tirtakusuma, K Szoltysek, P Milne, VV Grinev, A Ptasinska, PS Chin, ... Blood, The Journal of the American Society of Hematology 140 (17), 1875-1890, 2022 | 39 | 2022 |
| Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif P Zhou, AE Blain, AM Newman, M Zaka, G Chagaluka, FR Adlar, UT Offor, ... Blood advances 3 (14), 2118-2127, 2019 | 36 | 2019 |
| A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia NJ Sunter, K Scott, R Hills, D Grimwade, S Taylor, LJ Worrillow, ... Blood, The Journal of the American Society of Hematology 119 (1), 196-205, 2012 | 30 | 2012 |
Chris M BaconSenior Lecturer in Haematopathology, Newcastle Univeristy在 ncl.ac.uk 的电子邮件经过验证
